Literature DB >> 18239198

Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression.

Michael A Rapp1, Michal Schnaider-Beeri, Dushyant P Purohit, Daniel P Perl, Vahram Haroutunian, Mary Sano.   

Abstract

OBJECTIVE: Recent evidence suggests that a history of major depression may lead to increases in hippocampal neuropathology in Alzheimer disease (AD). The authors tested the hypothesis that neuritic plaques and neurofibrillary tangles are more pronounced in the brains of patients with AD with comorbid depression as compared with patients with AD without depression.
METHODS: Brain samples from patients were selected from the U.S. National Alzheimer's Coordinating Center database. The primary analysis included 7164 individuals: 6468 had AD as the primary neuropathologic diagnosis and 696 were considered neuropathologically normal. Depression at study inclusion was rated as present or absent in consensus conferences. Neuropathologic ratings from the Consortium to Establish a Registry in Alzheimer's Disease rating of neuritic plaques and Braak staging of neurofibrillary tangles were used for between-group analyses.
RESULTS: Brains of patients with AD with comorbid depression showed higher levels of cortical tangle formation than brains of patients with AD without comorbid depression. Results remained stable when controlling for age, gender, level of education, and cognitive status. Within patients with AD, comorbid depression increased the odds for advanced neuropathologic disease stage (odds ratio: 1.47; 95% confidence interval: 1.03-2.08).
CONCLUSION: In AD, the presence of depression comorbidity corresponds to increases in AD-related neuropathologic changes beyond age, gender, level of education, and cognitive status, suggesting an interaction between depression and the neuropathologic processes in AD.

Entities:  

Mesh:

Year:  2008        PMID: 18239198     DOI: 10.1097/JGP.0b013e31816029ec

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  64 in total

1.  Effects of Comorbid Depression and Diabetes Mellitus on Cognitive Decline in Older Mexican Americans.

Authors:  Brian Downer; Benjamin N Vickers; Soham Al Snih; Mukaila Raji; Kyriakos S Markides
Journal:  J Am Geriatr Soc       Date:  2016-01       Impact factor: 5.562

2.  Clinicopathological correlates of depression in early Alzheimer's disease in the NACC.

Authors:  Sarah T McCutcheon; Dingfen Han; Juan Troncoso; Vassilis E Koliatsos; Marilyn Albert; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2016-02-14       Impact factor: 3.485

3.  Personality traits and risk of cognitive impairment and dementia.

Authors:  Antonio Terracciano; Yannick Stephan; Martina Luchetti; Emiliano Albanese; Angelina R Sutin
Journal:  J Psychiatr Res       Date:  2017-01-22       Impact factor: 4.791

4.  Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.

Authors:  Matthias Brendel; Oliver Pogarell; Guoming Xiong; Andreas Delker; Peter Bartenstein; Axel Rominger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-29       Impact factor: 9.236

Review 5.  Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors.

Authors:  Irene Bolea; Alejandro Gella; Mercedes Unzeta
Journal:  J Neural Transm (Vienna)       Date:  2012-12-13       Impact factor: 3.575

6.  Organic bases of late-life depression: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2013-01-25       Impact factor: 3.575

7.  CSF biomarkers of Alzheimer disease: "noncognitive" outcomes.

Authors:  Catherine M Roe; Anne M Fagan; Elizabeth A Grant; David M Holtzman; John C Morris
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

8.  Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.

Authors:  Jennifer S Rabin; Zahra Shirzadi; Walter Swardfager; Bradley J MacIntosh; Aaron Schultz; Hyun-Sik Yang; Rachel F Buckley; Jennifer R Gatchel; Dylan Kirn; Jeremy J Pruzin; Trey Hedden; Nir Lipsman; Dorene M Rentz; Sandra E Black; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  Neurobiol Aging       Date:  2020-03-07       Impact factor: 4.673

9.  Posterior Cingulate and Lateral Parietal Gray Matter Volume in Older Adults with Depressive Symptoms.

Authors:  Michele L Ries; Allison Wichmann; Barbara B Bendlin; Sterling C Johnson
Journal:  Brain Imaging Behav       Date:  2009-04-15       Impact factor: 3.978

Review 10.  Pathways linking late-life depression to persistent cognitive impairment and dementia.

Authors:  Meryl A Butters; Jeffrey B Young; Oscar Lopez; Howard J Aizenstein; Benoit H Mulsant; Charles F Reynolds; Steven T DeKosky; James T Becker
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.